RecruitingOrnithine Transcarbamylase DeficiencyOrnithine Transcarbamylase Deficiency DiseaseUrea Cycle Disorders, Inborn
Long-term Follow-up (LTFU) Study of Participants in Any iECURE Protocol Using an Investigational Product (IP)
Eligible age
0.6–1.3 yrs
Accepts
All genders
Locations
2 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This LTFU is being conducted to assess long-term safety and durability of response in participants dosed with IP in a parent protocol, and to collect longitudinal natural history in enrolled but not dosed participants who also participated in a parent protocol.
Sponsor: iECURE, Inc.
You may qualify if…
- ✓ 1. Enrolled in an iECURE parent protocol and have either completed or discontinued that protocol
- ✓ 2. Participant parent(s)/LAR is willing and able to adhere to the protocol requirements.
- ✓ 3. Consent was obtained by the participants parent(s)/LAR (and participant assent, where applicable), prior to any study-related data being collected.
You may not qualify if…
- ✕ 1\. Participants who enroll into an interventional drug or gene therapy clinical trial utilizing an IP other than the IP provided in the parent protocol will be excluded from this protocol.
Where it's recruiting
Source: ClinicalTrials.gov · NCT06805695 · last updated 2026-11-05